Management of Acute Non‑Radicular Low Back Pain
Recommendations Against Systemic Corticosteroids
- The American College of Physicians (ACP) recommends that systemic corticosteroids should not be used for acute non‑radicular low back pain because they provide no benefit over placebo in pain intensity or functional outcomes; this recommendation is based on high‑quality guideline evidence from a 2017 systematic review. 1
First‑Line Pharmacologic Therapy
NSAIDs Monotherapy
- ACP advises initiating treatment with a non‑steroidal anti‑inflammatory drug (NSAID) as monotherapy for acute inflammatory back pain that does not improve with initial conservative measures; moderate‑quality evidence supports a modest reduction in pain and improvement in disability scores. 1
- No specific NSAID has demonstrated superiority; clinicians should prescribe the maximum tolerated dose of any NSAID, a recommendation supported by moderate‑quality evidence. 2
Adding Skeletal Muscle Relaxants
- When NSAID monotherapy is insufficient, adding a skeletal muscle relaxant to the NSAID regimen provides moderate‑quality evidence for short‑term pain relief in acute back pain. 1
Situations Where Corticosteroids May Be Considered
- For radicular pain with sciatica, limited (lower‑quality) evidence suggests a modest benefit of opioids, but systemic corticosteroids remain not recommended as standard therapy. 3
Bridging Corticosteroid Use in Other Inflammatory Conditions (Not for Acute Back Pain)
- Expert consensus recommends short‑course prednisone as bridging therapy while awaiting the effect of disease‑modifying agents; long‑term glucocorticoid use should be avoided. [2][4]
- Typical bridging doses are 10–20 mg daily for moderate disease activity and 0.5–1 mg/kg for severe inflammatory conditions; these dosing regimens do not apply to acute back pain. 4
Clinical Pitfalls to Avoid
- Do not prescribe a “burst‑and‑taper” prednisone regimen for routine acute back pain, as it lacks supporting evidence and exposes patients to unnecessary corticosteroid risks. 1
- Provide patient education that most acute back pain improves over time with NSAIDs and activity modification; this recommendation is grounded in ACP guideline evidence. 1
Management of Acute-on-Chronic Back Pain with Muscle Spasm
Evidence Against Corticosteroid Use
- The American College of Physicians guidelines state that systemic corticosteroids show no difference in pain or function compared with placebo in patients with acute low back pain, based on low-quality evidence from multiple trials 5, 6, 7, 8
- For non-radicular back pain, the American College of Physicians found that systemic corticosteroids may be associated with no benefit, and the American College of Physicians guidelines recommend against their use 5, 6, 7, 8
What Actually Works for Muscle Spasm
- The American College of Physicians recommends using skeletal muscle relaxants combined with NSAIDs for acute back pain with muscle spasm, as they provide moderate-quality evidence for short-term pain relief 5, 6, 7, 8
- Moderate-quality evidence shows that NSAIDs provide small improvement in pain intensity versus placebo, with no specific NSAID being superior to another 5, 6, 7, 8
- Adding a muscle relaxant to NSAIDs increases CNS adverse events but may reduce GI adverse events 9, 10